RxDoctor Payments Data

Sachin Kukreja, MD

Surgery · Dallas, TXNPI 1528214590

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (51.5%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 97.0% of it on its own, with 28 other manufacturers making up the rest. Reporting peaked in 2022 at $147,051 and has fallen 75.1% since, to $36,648 in 2025. Among surgery clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$639,795in general payments, 2019–2025

Across 1,015 payments — averaging $630.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$621K
  • Conmed Corporation$6K
  • Apollo Endosurgery US Inc$6K
  • Aesculap, Inc.$4K
  • Novo Nordisk$567
  • Davol Inc.$400
  • plus $2K from 23 others
$4,768in research payments, 2019–2025

Across 2 payments — averaging $2384.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Intuitive Surgical Operations, Inc.$5K

What the payments were for

  • Consulting fees$10,8502%
  • Speaking & faculty fees$207,60032%
  • Travel & lodging$54,6879%
  • Food & beverage$37,2366%
  • Education$329,40051%
  • Gifts$220%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$639,795 in reported general payments places this provider in the 95th percentile of 1,830 surgery providers in Texas.

See all surgery providers in Texas

Medicare billing

Part B allowed, 2024
$25,871
Medicare patients
58
Services billed
101

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ondansetron OdtOndansetron13$159
Gabapentin12$37

Paid to pharmacies, not to this prescriber.

Other surgery in Dallas

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →